Management of Biliopleural Fistula after Transarterial Chemoembolization of a Liver Lesion

Management of Biliopleural Fistula after Transarterial Chemoembolization of a Liver Lesion

A case of a biliopleural fistula with a biloma occurring after superselective hepatic transarterial chemoembolization ablation of a metastatic hepatic carcinoid is described. The presentation was complicated by choledocholithiasis. The biloma was successfully treated with endoscopic drainage.

Bibliographic Details
Main Authors:	Amir Shahzad Butt, Ghulam Mujtaba, Sury Anand, Mahesh Krishnaiah
Format:	Article
Language:	English
Published:	Hindawi Limited 2010-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/2010/790726

Similar Items

Fístula biliopleural de origen traumático
by: Patricio Vanerio, et al.
Published: (2019-07-01)

Efficacy of Transarterial Chemoembolization on Lesion Reduction in Colorectal Liver Metastases
by: Hossein Ghanaati, et al.
Published: (2012-08-01)

Efficacy of Transarterial Chemoembolization on Lesion Reduction in Colorectal Liver Metastases
by: Hossein Ghanaati, et al.
Published: (2012-08-01)

Nonoperative management of biliopleural fistula following living‐donor liver transplantation: A case report
by: Kourosh Kazemi, et al.
Published: (2023-11-01)

Transarterial Chemoembolization of Metastatic Liver Lesions in Patients with Colorectal Cancer
by: O. Yu. Stukalova, et al.
Published: (2019-12-01)

Uso de colangiopancreatografía retrógrada endoscópica en pacientes con fístula biliopleural
by: Edson R. Marcos-Ramírez, et al.
Published: (2021-01-01)

Transarterial chemoembolization for primary and metastatic liver tumors
by: Popov M.V., et al.
Published: (2016-12-01)

Laparoscopic closure of gastrohepatic fistula complicated by transarterial chemoembolization for hepatocellular carcinoma
by: Wei-Yi Liu, et al.
Published: (2024-10-01)

Late onset of biliopleural fistula following percutaneous transhepatic biliary drainage: a case report
by: Yi-Yung Yu Edward, et al.
Published: (2018-03-01)

RESULTS OF TRANSARTERIAL CHEMOEMBOLIZATION OF STOMACH CANCER METASTASES IN THE LIVER
by: D. T. Arybzhanov
Published: (2017-02-01)

Multiple acute complications of transarterial chemoembolization of liver metastases
by: R. N. Abu Shamsia, et al.
Published: (2024-12-01)

Transarterial chemoembolization for patients with metastatic uveal melanoma in the liver
by: B. I. Dolgushin, et al.
Published: (2016-09-01)

Biodegradable Microspheres for Transarterial Chemoembolization in Malignant Liver Disease
by: Ornella Moschovaki-Zeiger, et al.
Published: (2024-04-01)

Transarterial chemoembolization and early arterial complications after liver transplantation for hepatocellular carcinoma
by: V. V. Borovik, et al.
Published: (2022-09-01)

Xanthogranulomatous pleuritis induced by recurrent biliothorax due to a biliopleural fistula: The first case report in the literature
by: Moatasem Hussein Al-janabi, et al.
Published: (2024-01-01)

The impact of liver abscess formation on prognosis of patients with malignant liver tumors after transarterial chemoembolization
by: Yunan Wang, et al.
Published: (2023-11-01)

Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the LiverT study
by: Rebecca A. Miksad, et al.
Published: (2019-08-01)

Outcomes of repeat conventional transarterial chemoembolization in patients with liver metastases
by: Kamyar Ghabili, et al.
Published: (2024-11-01)

Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma
by: Rusi Zhang, et al.
Published: (2018-07-01)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
by: Baur J, et al.
Published: (2016-06-01)

Transarterial chemoembolization alone or followed by bevacizumab for treatment of colorectal liver metastases
by: Giammaria Fiorentini, et al.
Published: (2022-03-01)

The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
by: Seong Kyun Na, et al.
Published: (2018-01-01)

Endoscopic closure of persistent gastrocutaneous fistulae, after percutaneous endoscopic gastrostomy (PEG) tube placement, using the over-the-scope-clip system
by: Shashideep Singhal, et al.
Published: (2015-07-01)

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review
by: Rahmad Mulyadi, et al.
Published: (2024-05-01)

Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma
by: Shuling Chen, et al.
Published: (2019-04-01)

Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?
by: Tamás Benkö, et al.
Published: (2022-05-01)

Effects of Oral L-Carnitine on Liver Functions after Transarterial Chemoembolization in Intermediate-Stage HCC Patients
by: Abeer Hassan, et al.
Published: (2015-01-01)

Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation
by: Xia Zhang, et al.
Published: (2023-01-01)

Adjuvant Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy
by: Yue-Lin Zhang, et al.
Published: (2020-09-01)

Survival Benefit of Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Waqas Ahmad, et al.
Published: (2020-06-01)

Treatment Strategy of Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Shiro Miyayama
Published: (2020-10-01)

Transarterial Chemoembolization in Hepatocellular Carcinoma, Albanian Experience.
by: Ilirian Laçi, et al.
Published: (2022-07-01)

Ultraselective conventional transarterial chemoembolization: When and how?
by: Shiro Miyayama
Published: (2019-12-01)

Impact of Hyperglycemia on Complication and Mortality after Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Sun Joon Moon, et al.
Published: (2024-03-01)

Factors Predicting Survival after Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma
by: Farina M. Hanif, et al.
Published: (2014-10-01)

Spontaneous regression of lung metastases after transarterial chemoembolization for hepatocellular carcinoma
by: Naoko Kakuta, MD, et al.
Published: (2021-06-01)

Transarterial Chemoembolization Plus Sorafenib versus Transarterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma: An Umbrella Review of Meta-Analyses and Systematic Reviews
by: Yan J, et al.
Published: (2023-10-01)

Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
by: Jun-Ning Liu, et al.
Published: (2023-02-01)

Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.
by: Hao Hu, et al.
Published: (2014-01-01)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
by: Yanqiao Ren, et al.
Published: (2022-03-01)